Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as a REIT (property company): Dividend discount.
ACCE opinionMedical Properties Trust Inc. common stock (MPT)
Fair value (2 models)
Not available
ACCE price target
$3.10
Rating
Not rated
Horizon
12 months
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Price used: $2.70 at the close on 23 Oct 2026, 22:00 CEST.
Models: Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
39
out of 100
Analysts
38% buy
8 covering
1-year return
-46.6%
Dividend yield
13.28%
Medical Properties Trust Inc. common stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Medical Properties Trust owns hospital real estate and leases the buildings, mostly to operators of acute care hospitals, many of them in the US, the UK, Germany and other European markets. Its structural appeal is the triple-net lease structure, which pushes most operating costs onto tenants and produces a 95.9% gross margin and a 57.4% operating margin on the reported figures. The problem is the tenant base: rent is only as durable as the operators paying it, and recent years have shown how quickly that can change. Revenue growth is just 1.9%, ROE is slightly negative at -0.6%, and the 39/100 score reflects that weak earnings base. With a forward P/E of 6.7 and no index membership, the stock is priced for a meaningful amount of tenant risk, so the case rests on whether rent collection and lease resets hold up, which is the question to answer before going further.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
severe
Extreme short interest
Short interest sits at 32.8% of the float, a level that signals either a deeply contested thesis or a squeeze risk, and it makes the stock prone to violent swings unrelated to fundamentals.
high
Leverage well above norms
Debt/Equity of 2.13 with free cash flow of $231M leaves little room for error if rents or tenant payments weaken.
high
Shrinking revenue base
Revenue has fallen at a 4.9% CAGR over five years, and earnings growth is flat at 0.0% with revenue up only 1.9% YoY.
moderate
Score deteriorating
The ACCE score dropped from 49 to 41 over 90 days, with growth (G:19) and momentum (M:17) the weakest components.
AI research notes
AI-assisted·How I use AIWritten Oct 22, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Free cash flow over the last twelve months was $231M, so the business still generates real cash despite its losses.
The stock offers a 13.1% dividend yield and a 13.6% free cash flow yield at the current $2.70 share price.
Analysts' mean price target sits 94.9% above the share price, though only 3 of 8 analysts rate the stock Buy or Strong Buy.
Why it could disappoint
Net margin was -2.7% and return on equity was -0.6%, so the company is still losing money on its revenue and capital.
Debt equals 2.13 times equity, and the company missed its latest earnings estimate by 6.3%, leaving little room for error.
Revenue shrank 4.9% a year on average over five years, and hospital operators' rent defaults threaten the rental income that drives the business.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where MPT's valuation models land
Price
$2.70
Model fair valueConfidence: medium
$1.37
Model
Fair value
Upside
Dividend discount
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores